Table 4.
Variable | Univariate | Multivariate Analysis | ||
---|---|---|---|---|
P | P | HR | 95% CI | |
Age at diagnosis | <0·0001 | <0·0001 | 1·045 | 1·026–1·065 |
Clonal evolution at diagnosis | 0·031 | 0·028 | 2·841 | 1·121–7·149 |
Sokal risk Score | 0·15 | |||
Type of TKIs | 0·45 | |||
Time from diagnosis to TKI | 0·26 | |||
Cumulative response with a time dependent variable* | ||||
CCyR | <0·0001 | <0·0001 | 6·250 | 3·367–11·494 |
MMR | <0·0001 | <0·0001 | 6·579 | 3·745–11·628 |
MR4·5 | <0·0001 | <0·0001 | 5·154 | 2·841–9·346 |
CMR | <0·0001 | 0·0013 | 3·003 | 1·538–5·882 |
Each variable was compared to the counterpart no response category and calculated for multivariate analysis separately.
Abbreviations: TKI, tyrosine kinase inhibitor; HR, hazard ratio; CI, confidence interval; CCyR, complete cytogenetic response; MMR, major molecular response; MR4·5, molecular response with 4·5 log reduction by international scale; CMR, complete molecular response; OS, overall survival.